Skip to main content

Table 4 Antimicrobial susceptibility of E. coli, K. pneumoniae and P. aeruginosa infections

From: Acute bacterial prostatitis and abscess formation

  With abscess Without abscess
  E. coli (n (%)) K. pneumoniae (n (%)) P. aeruginosa (n (%)) E. coli (n (%)) K. pneumoniae (n (%)) P. aeruginosa (n (%))
Amikacin S 7/7 (100.0) S 6/6 (100.0) S 3/4 (75.0) S 71/71 (100.0) S 8/8 (100.0) S 4/4 (100.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 0/7 R 0/6 R ¼ R 0/71 R 0/8 R 0/4
Amoxicillin S 4/7 (57.1) S 0/6 (0.0) NA S 31/71 (43.7) S 0/8 (0.0) NA
I 0/7 I 0/6 I 0/71 I 0/8
R3/7 R 6/6 R 40/71 R 8/8
Amoxicillin/clavulanic acid S 5/7 (71.4) S 6/6 (100.0) NA S 48/71 (67.6) S 8/8 (100.0) NA
I 2/7 I 0/6 I 17/71 I 0/8
R 0/7 R 0/6 R 6/71 R 0/8
Aztreonam S 5/7 (71.4) S 6/6 (100.0) S 1/4 (25.0) S 65/71 (91.5) S 8/8 (100.0) S 2/4 (50.0)
I 0/7 I 0/6 I 1/4 I 0/74 I 0/8 I 1/4
  R 2/7 R 0/6 R 2/4 R 6/74 R 0/8 R 1/4
Cefazolin S 5/7 (71.4) S 6/6 (100.0) NA S 54/71 (76.1) S 8/8 (100.0) NA
I 0/7 I 0/6 I 0/71 I 0/8
R 2/7 R 0/6 R 17/71 R 0/8
Cefepime S 5/7 (71.4) S 6/6 (100.0) S 3/4 (75.0) S 67/71 (94.4) S 8/8 (100.0) S 3/4 (75.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 1/4
R 2/7 R 0/6 R ¼ R 4/71 R 0/8 R 0/4
Cefotaxime S 5/7 (71.4) S 6/6 (100.0) S 0/4 (0.0) S 59/71 (83.1) S 8/8 (100.0) S 0/4 (0.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 2/7 R 0/6 R 4/4 R 12/71 R 0/8 R 4/4
Cefoxitin S 7/7 (100.0) S 6/6 (100.0) NA S 68/71 (95.8) S 8/8 (100.0) NA
I 0/0 I 0/6   I 2/71 I 0/8
R 0/0 R 0/6   R 1/71 R 0/8
Ceftazidime S 5/7 (71.4) S 6/6 (100.0) S 3/4 (75.0) S 68/71 (95.8) S 8/8 (100.0) S 4/4 (100.0)
I 0/7 I 0/6 I 0/4 I 0/74 I 0/8 I 0/4
R 2/7 R 0/6 R 1/4 R 3/71 R 0/8 R 0/4
Ciprofloxacin S 5/7 (71.4) S 6/6 (100.0) S 3/4 (75.0) S 58/71 (81.7) S 7/8 (87.5) S 3/4 (75.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 2/7 R 0/6 R 1/4 R 13/71 R 1/8 R 1/4
Imipenem S 7/7 (100.0) S 6/6 (100.0) S 4/4 (100.0) S 71/71 (100.0) S 8/8 (100.0) S 4/4 (100.0)
I 0/0 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 0/0 R 0/6 R 0/4 R 0/71 R 0/8 R 0/4
Piperacillin/tazobactam S 7/7 (100.0) S 6/6 (100.0) S 2/4 (50.0) S 68/71 (95.8) S 7/8 (87.5) S 4/4 (100.0)
I 0/0 I 0/6 I 1/4 I 1/71 I 1/8 I 0/4
R 0/0 R 0/6 R 1/4 R 2/71 R 0/8 R 0/4
Cotrimoxazole S 5/7 (71.4) S 6/6 (100.0) S 0/4 (0.0) S 56/71 (78.9) S 6/8 (75.0) S 0/4 (0.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 2/7 R 0/6 R 4/4 R 15/71 R 2/8 R 4/4
  1. Susceptible categories (S/I/R: Sensitive/Intermediate/Resistant)